Evidence map›Paper›PMID 34289367›Full record

ArticleCell reports2021

Phosphorylated WNK kinase networks in recoded bacteria recapitulate physiological function.

Paula Schiapparelli, Natasha L Pirman, Kyle Mohler, Pierre A Miranda-Herrera, Natanael Zarco, Onur Kilic, Chad Miller, Sagar R Shah, Svetlana Rogulina, William Hungerford and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Structural bases for NaNature communications · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Paula SchiapparelliDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Natasha L PirmanDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA; Systems Biology Institute, Yale University, West Haven, CT 06516, USA.
Kyle MohlerDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA; Systems Biology Institute, Yale University, West Haven, CT 06516, USA.
Pierre A Miranda-HerreraDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Natanael ZarcoDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Onur KilicDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, USA.
Chad MillerDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Sagar R ShahDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, USA.
Svetlana RogulinaDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA; Systems Biology Institute, Yale University, West Haven, CT 06516, USA.
William HungerfordYale Center for Molecular Discovery, Yale University, West Haven, CT 06516, USA.
Laura AbriolaYale Center for Molecular Discovery, Yale University, West Haven, CT 06516, USA.
Denton HoyerYale Center for Molecular Discovery, Yale University, West Haven, CT 06516, USA.
Benjamin E TurkDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Hugo Guerrero-CázaresDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Farren J IsaacsSystems Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Molecular, Cellular & Developmental Biology, Yale University, New Haven, CT 06520, USA; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.
Alfredo Quiñones-HinojosaDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
Andre LevchenkoDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA; Department of Molecular, Cellular & Developmental Biology, Yale University, New Haven, CT 06520, USA; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.
Jesse RinehartDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA; Systems Biology Institute, Yale University, West Haven, CT 06516, USA. Electronic address: jesse.rinehart@yale.edu.
Yale University · USMayo Clinic in Florida · USJohns Hopkins University · US

Funding

Systems analysis of phenotypic switch in control of cancer invasionU54CA209992 · NCI · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2016 to 2021
$10.1M
Revealing substrates and phosphoproteome level function of human STE20 kinasesR01GM117230 · NIGMS · YALE UNIVERSITY · PI ISAACS, FARREN J., RINEHART, JESSE · 2015 to 2024
$3.2M
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical ImagingR01CA200399 · NCI · JOHNS HOPKINS UNIVERSITY · PI LI, XINGDE, QUINONES-HINOJOSA, ALFREDO · 2016 to 2020
$3.0M
NCI NIH HHS R01 CA200399NCI NIH HHS U54 CA209992NIGMS NIH HHS R01 GM117230
6 · The paper itself

Abstract

Advances in genetic code expansion have enabled the production of proteins containing site-specific, authentic post-translational modifications. Here, we use a recoded bacterial strain with an expanded genetic code to encode phosphoserine into a human kinase protein. We directly encode phosphoserine into WNK1 (with-no-lysine [K] 1) or WNK4 kinases at multiple, distinct sites, which produced activated, phosphorylated WNK that phosphorylated and activated SPAK/OSR kinases, thereby synthetically activating this human kinase network in recoded bacteria. We used this approach to identify biochemical properties of WNK kinases, a motif for SPAK substrates, and small-molecule kinase inhibitors for phosphorylated SPAK. We show that the kinase inhibitors modulate SPAK substrates in cells, alter cell volume, and reduce migration of glioblastoma cells. Our work establishes a protein-engineering platform technology that demonstrates that synthetically active WNK kinase networks can accurately model cellular systems and can be used more broadly to target networks of phosphorylated proteins for research and discovery.

Indexed as

Signal TransductionAmino Acid SequenceAnimalsCell Line, TumorCell MovementCell ProliferationEscherichia coliFemaleGlioblastomaHEK293 CellsHumansMaleMiceMice, NudeMiddle AgedPhosphorylationPhosphoserineProtein Serine-Threonine KinasesRecombinant ProteinsSmall Molecule LibrariesSTK39 protein, humanWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1glioblastoma cell migrationkinasesmall-molecule kinase inhibitorSPAKsynthetic biologyWNK1

Identifiers

PMID34289367
PMCPMC8379681
OpenAlexW3187019636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.